Research graph
References from Sociodemographic barriers to receiving adjuvant systemic therapy after nephrectomy for renal cell carcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.
Effect of social support and marital status on perceived surgical effectiveness and 30-day hospital readmission
10.1177/2192568217696696 · 2017 · External reference
Structural racism and health inequities in the USA: evidence and interventions
10.1016/s0140-6736(17)30569-x · 2017 · External reference
Incorporating intersectionality theory into population health research methodology: challenges and the potential to advance health equity
10.1016/j.socscimed.2014.03.022 · 2014 · External reference
The impact of demographics and socioeconomic status on the receipt of immunotherapy for stage III melanoma
10.1016/j.suronc.2024.102156 · 2024 · External reference
Racial disparities in nephrectomy and mortality among patients with renal cell carcinoma: findings from SEER
10.1371/journal.pgph.0001314 · 2023 · External reference
Other-cause mortality and access to care in metastatic renal cell carcinoma according to race/ethnicity
10.1016/j.urolonc.2022.06.022 · 2022 · External reference
Racial/ethnic differences in time to nephrectomy and its association with cancer-specific mortality in localized renal cell carcinoma
10.1007/s11255-026-05141-0 · 2026 · External reference
Racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era
10.1002/cncr.30146 · 2016 · External reference
Association between Food and Drug Administration approval and disparities in immunotherapy use among patients with cancer in the US
10.1001/jamanetworkopen.2022.19535 · 2022 · External reference
Adjuvant sunitinib in high-risk renal-cell carcinoma after nephrectomy
10.1056/nejmoa1611406 · 2016 · External reference
Adjuvant sunitinib for high-risk renal cell carcinoma after nephrectomy: subgroup analyses and updated overall survival results
10.1016/j.eururo.2017.09.008 · 2018 · External reference
Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma
10.1056/nejmoa2106391 · 2021 · External reference
Overall survival with adjuvant pembrolizumab in renal-cell carcinoma
10.1056/nejmoa2312695 · 2024 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline
10.1097/ju.0000000000001912 · 2021 · External reference
A plea for optimizing selection in current adjuvant immunotherapy trials for high-risk nonmetastatic renal cell carcinoma according to expected cancer-specific mortality
10.1016/j.clgc.2019.11.010 · 2020 · External reference
High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: a population-based analysis
10.18632/oncotarget.24675 · 2018 · External reference
Survival outcomes and practice trends for off-label use of adjuvant targeted therapy in high-risk locoregional renal cell carcinoma
10.1016/j.urolonc.2020.02.028 · 2020 · External reference
Demographic factors associated with Non-guideline–Based treatment of kidney cancer in the United States
10.1001/jamanetworkopen.2021.12813 · 2021 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Prognostic impact of adjacent organ invasion on cancer-specific mortality in non-metastatic renal cell carcinoma
10.1186/s12957-026-04511-3 · 2026 · External reference
Rates of adjacent organ invasion in non-metastatic renal cell carcinoma: a population-based study
10.1016/j.ejso.2026.111924 · 2026 · External reference
Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study
10.1007/s00345-025-05992-9 · 2025 · External reference
Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre study
10.1111/bju.16780 · 2025 · External reference
Tumor size improves the accuracy of TNM predictions in patients with renal cancer
10.1016/j.eururo.2006.02.034 · 2006 · External reference
A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma
10.1016/j.urolonc.2013.06.010 · 2014 · External reference
Effect of marital status on years of life lost from metastatic prostate cancer according to race/ethnicity
10.1002/pros.70130 · 2026 · External reference
Marital status and survival in patients with cancer
10.1200/jco.2013.49.6489 · 2013 · External reference
Intersectionality in cancer care: a systematic review of current research and future directions
10.1002/pon.5890 · 2022 · External reference
Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome
10.1097/00000478-200404000-00002 · 2004 · External reference
Prognostic significance of morphologic parameters in renal cell carcinoma
10.1097/00000478-198210000-00007 · 1982 · External reference
A strategy for health care reform–toward a value-based system
10.1056/nejmp0904131 · 2009 · External reference
